Your browser doesn't support javascript.
loading
Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trial.
Kvitne, Kine Eide; Robertsen, Ida; Skovlund, Eva; Christensen, Hege; Krogstad, Veronica; Wegler, Christine; Angeles, Philip Carlo; Wollmann, Birgit Malene; Hole, Kristine; Johnson, Line Kristin; Sandbu, Rune; Artursson, Per; Karlsson, Cecilia; Andersson, Shalini; Andersson, Tommy B; Hjelmesaeth, Jøran; Jansson-Löfmark, Rasmus; Åsberg, Anders.
Affiliation
  • Kvitne KE; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Robertsen I; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Skovlund E; Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.
  • Christensen H; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Krogstad V; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Wegler C; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Angeles PC; DMPK, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden.
  • Wollmann BM; Vestfold Hospital Trust, The Morbid Obesity Center, Tønsberg, Norway.
  • Hole K; Department of Surgery, Vestfold Hospital Trust, Tønsberg, Norway.
  • Johnson LK; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
  • Sandbu R; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
  • Artursson P; Vestfold Hospital Trust, The Morbid Obesity Center, Tønsberg, Norway.
  • Karlsson C; Vestfold Hospital Trust, The Morbid Obesity Center, Tønsberg, Norway.
  • Andersson S; Department of Surgery, Vestfold Hospital Trust, Tønsberg, Norway.
  • Andersson TB; Department of Pharmacy and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Hjelmesaeth J; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden.
  • Jansson-Löfmark R; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Åsberg A; Research and Early Development, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden.
Clin Transl Sci ; 15(1): 221-233, 2022 01.
Article in En | MEDLINE | ID: mdl-34435745

Full text: 1 Database: MEDLINE Main subject: Gastric Bypass / Weight Loss / Caloric Restriction / Cytochrome P-450 CYP3A Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Gastric Bypass / Weight Loss / Caloric Restriction / Cytochrome P-450 CYP3A Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2022 Type: Article